Pharmacology and artificial intelligence

Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortium

Jean-Baptiste Woillard, Sébastien Benzekry, Julie Josse, Mélanie White-Koning, Etienne Chatelut, Emmanuelle Comets, Florian Lemaitre, Bénédicte Franck, Matthieu Gregoire, Françoise Stanke-Labesque, Sarah Zohar, Moreno Ursino, Christophe Battail, on behalf of the DIGPHAT consortium

A new chapter in pharmacology: Artificial intelligence's expanding role in pharmacokinetics, pharmacodynamics, and pharmacovigilance

Alexandre O. Gérard, Romain Lombardi, Diane Merino, Charles Bouveyron, Jean Dellamonica, Milou-Daniel Drici, Thibaud Lavrut, Alexandre Destere

Pharmacovigilance

Isolated depressive disorders and suicidality with finasteride use for androgenetic alopecia: A call for enhanced vigilance

Hélène Géniaux, Marie-Laure Laroche

Letter to editor

Fluoxetine-induced lower limb ecchymosis in an adolescent: A case report and literature review

Thomas Darque, Clément Pruvot, Paul Nadin, Paola Sanchez-Pena, Myrtille Hamm, Juliette Miquel

Pharmacovigilance

Risque d’ulcérations cutanéo-muqueuses lié au nicorandil : données récentes de la base nationale de pharmacovigilance française et du programme de médicalisation des systèmes d’information (NICORUC)

Risk of mucocutaneous ulcerations associated with nicorandil: Recent data of the French Pharmacovigilance DataBase and Toulouse Hospital Discharge DataBase (NICORUC)

Liliane Batty, Joanna Lapalus, Elsa Trime, Pauline Schiro, Romain Barus, Didier Fabre, Johana Béné, Julien Moragny, Viktoryia Prontskus, Haleh Bagheri

Letter to Editor

Progressive outer retinal necrosis complicating aseptic meningitis due to varicella zoster virus reactivation 44 days after infusion of natalizumab

Hidaya Drissi Oudghiri, Thomas Ferreira De Moura, Brahim Azzouz, Catherine Feliu, Michael Hoang, Aurélie Brunet, Véronique Brodard, Yohan N’Guyen

Addictologie

Mise en place d’un sevrage de benzodiazépines avec substitution par le prazépam : Étude rétrospective auprès de 86 patients

Amir Kallab Debbih, Christophe Cutarella, Elisabeth Jouve, Michel Spadari, Joelle Micallef, Elisabeth Frauger

Drugs associated with behavioral addictions: Real world analysis using the WHO pharmacovigilance database

Louis Asselin, Edouard-Jules Laforgue, Mélanie Duval, Bruno Revol, Gwenaëlle Veyrac, Marie Grall-Bronnec, Caroline Victorri-Vigneau

Impact of urine drug screening on opioid agonist treatment maintenance with buprenorphine in primary care in France: A cluster-randomized trial

Julie Dupouy, Vanessa Rousseau, Nicolas Authier, Paolo Di Patrizio, Gaetan Gentile, Valérie Gibaja, Catherine Laporte, Laurent Letrilliart, Christine Maynié, Joëlle Micallef, Michel Mallaret, Stéphane Oustric, Emilie Bérard, Maryse Lapeyre-Mestre

Pharmacovigilance

A new tool to study the effects of in utero medication exposure on neurodevelopment in children

Laurane Delteil, Caroline Hurault-Delarue, Catherine Arnaud, Dana Klapouszczak, Isabelle Lacroix, Malika Delobel-Ayoub

Safety of SARS-CoV-2 vaccination of pregnant women: Luxembourg's cohort study and literature review

Victoria Ugolini, Nadine Petitpain, Didier Menzies, Dominique Swiegot, Audrey Fresse, Isabel De La Fuente Garcia, Anne-Cécile Vuillemin

Letter to editor

Methylphenidate-associated eosinophilia in a child: A case report

Aurélie Bobet, Marion Broquere, Philippe Pauly, Thiébaut-Noël Willig, Haleh Bagheri